Add like
Add dislike
Add to saved papers

Reliability and Validity of the Turkish Translation of the PedsQLTM 3.0 Neuromuscular Module for 2-to 4- Year-old in Spinal Muscular Atrophy.

Neuropediatrics 2024 March 16
BACKGROUND: The Pediatric Quality of Life InventoryTM Neuromuscular Module (PedsQLTM 3.0 NM) evaluates the health-related quality of life in children who are affected by neuromuscular diseases. This study's aim is to assess the adaptation of the PedsQLTM 3.0 NM Turkish version (PedsQLTM 3.0 NM-TR) for 2-4 years old in spinal muscular atrophy (SMA).

METHODS: The procedure of translating the PedsQLTM 3.0 NM into Turkish was conducted in accordance with the translation methodology outlined by the PedsQLTM measurement model. The PedsQLTM 3.0 NM-TR was administered to 54 parents of children with SMA aged 2-4 years. The test-retest reliability and intraclass correlation coefficient (ICC) were measured for reliability analysis. Cronbach's alpha coefficient and item score correlations were calculated for internal consistency. Concurrent construct validity was evaluated by Pearson correlations between the outcomes of the PedsQLTM 4.0 Generic Core Scale (PedsQLTM 4.0 GCS) and the PedsQLTM 3.0 NM.

RESULTS: The PedsQLTM 3.0 NM-TR total score shows excellent reliability. The Cronbach's alpha values for the PedsQLTM 3.0 NM ranged between 0.871-0.906, while those for the PedsQLTM 4.0 GCS ranged 0.843-0.897. Test-retest ICC values for the PedsQLTM 3.0 NM-TR ranged 0.812-0.917, and for the PedsQLTM 4.0 GCS ranged 0.773-0.899. The relationship between the PedsQLTM 3.0 NM-TR and the subscores of the PedsQLTM 4.0 GCS demonstrated a range of correlations from excellent to fair, indicating the interplay between two scales.

CONCLUSIONS: This study established the PedsQLTM 3.0 NM-TR as reliable, valid, and feasible for use in children aged 2-4 years old with SMA.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app